sk&f-38393 has been researched along with tetrodotoxin in 24 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (12.50) | 18.7374 |
1990's | 13 (54.17) | 18.2507 |
2000's | 4 (16.67) | 29.6817 |
2010's | 4 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cazin, L; Louiset, E; Valentijn, JA; Vaudry, H | 1 |
Kurata, K; Shibata, R | 1 |
Feletou, M; Vanhoutte, PM | 1 |
Czarnecki, B; Gorell, JM | 1 |
Besson, MJ; Girault, JA; Glowinski, J; Savaki, HE; Spampinato, U | 1 |
Abarca, J; Bustos, G; Gysling, K; Roth, RH | 1 |
Cano, J; Machado, A; Santiago, M | 1 |
Giambalvo, CT; Wagner, RL | 1 |
Frankenschmidt, A; Rump, LC; Schaible, U; Schollmeyer, PJ; Schuster, MJ; Schwertfeger, E | 1 |
Bernardi, G; Calabresi, P; Mercuri, NB; Sancesario, G | 1 |
Bargas, J; Galarraga, E; Hernández-López, S; Pacheco-Cano, MT; Tapia, D | 1 |
Dahmer, MK; Senogles, SE | 1 |
Matuszewich, L; Yamamoto, BK | 1 |
Gáborján, A; Lendvai, B; Vizi, ES | 1 |
Giuffrida, A; Kerr, TM; Navarro, M; Parsons, LH; Piomelli, D; Rodríguez de Fonseca, F | 1 |
Bouron, A; Reuter, H | 1 |
Gorelova, NA; Yang, CR | 1 |
Salvi, RJ; Sun, W | 1 |
Bernardi, G; Bracci, E; Calabresi, P; Centonze, D; Gubellini, P; Pisani, A | 1 |
Cox, CL; Govindaiah, G | 1 |
Fujita, T; Kumamoto, E; Miyazaki, N; Nakatsuka, T; Takeda, D; Taniguchi, W; Yamada, H; Yoshida, M | 1 |
Berson, DM; Van Hook, MJ; Wong, KY | 1 |
Akimoto, N; Furue, H; Ikeda, A; Naitou, K; Nakamori, H; Nozue, Y; Sano, Y; Shiina, T; Shimizu, Y; Yamada, A; Yamamoto, Y; Yokoyama, T | 1 |
Amodeo, I; Auteri, M; Caldara, G; Cavallaro, G; Di Carlo, M; Fumagalli, M; Mastropaolo, M; Mosca, F; Mule, F; Nuzzo, D; Serio, R; Zizzo, MG | 1 |
24 other study(ies) available for sk&f-38393 and tetrodotoxin
Article | Year |
---|---|
Dopamine-induced inhibition of action potentials in cultured frog pituitary melanotrophs is mediated through activation of potassium channels and inhibition of calcium and sodium channels.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Action Potentials; Animals; Calcium Channel Blockers; Calcium Chloride; Dopamine; In Vitro Techniques; Male; Melanins; Membrane Potentials; Pituitary Gland; Potassium Channels; Rana ridibunda; Sodium Channels; Sulpiride; Tetrodotoxin | 1991 |
Biphasic effect of locally applied apomorphine and 2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine on the release of striatal dopamine investigated by means of brain dialysis.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Brain Chemistry; Chromatography, High Pressure Liquid; Corpus Striatum; Dialysis; Dopamine; Dopamine Agents; Ergolines; Male; Quinpirole; Rats; Rats, Inbred Strains; Tetrodotoxin | 1990 |
Tetrodotoxin-insensitive relaxation of coronary arterial smooth muscle to electrical stimulation: possible involvement of a dopaminergic mechanism.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Calcium; Cattle; Coronary Vessels; Dogs; Dopamine; Electric Stimulation; Female; Hydroxydopamines; In Vitro Techniques; Male; Oxidopamine; Receptors, Dopamine; Scorpion Venoms; Swine; Tetraethylammonium Compounds; Tetrodotoxin; Vasodilation | 1989 |
Pharmacologic evidence for direct dopaminergic regulation of striatal acetylcholine release.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Acetylcholine; Animals; Benzazepines; Corpus Striatum; Ergolines; Male; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride; Tetrodotoxin | 1986 |
In vivo release of [3H]gamma-aminobutyric acid in the rat neostriatum--I. Characterization and topographical heterogeneity of the effects of dopaminergic and cholinergic agents.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Acetylcholine; Animals; Benzazepines; Calcium; Corpus Striatum; Dopamine; gamma-Aminobutyric Acid; Male; Phenethylamines; Potassium; Rats; Rats, Inbred Strains; Tetrodotoxin | 1986 |
Changes in extracellular levels of glutamate and aspartate in rat substantia nigra induced by dopamine receptor ligands: in vivo microdialysis studies.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Aspartic Acid; Benzazepines; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Ergolines; Extracellular Space; Glutamic Acid; Kinetics; Ligands; Male; Microdialysis; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Spiperone; Substantia Nigra; Tetrodotoxin; Time Factors | 1995 |
Regulation of prefrontal cortical dopamine release by dopamine receptor agonists and antagonists.
Topics: 1-Methyl-4-phenylpyridinium; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Calcium; Dopamine; Dopamine Agents; Dopamine D2 Receptor Antagonists; Drug Interactions; Male; Microdialysis; Nomifensine; Potassium; Prefrontal Cortex; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride; Tetrodotoxin | 1993 |
Activation of D1 and D2 dopamine receptors inhibits protein kinase C activity in striatal synaptoneurosomes.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Calcium; Corpus Striatum; Dopamine Agents; Dose-Response Relationship, Drug; Enzyme Activation; Ergolines; Fenoldopam; Male; Phenethylamines; Protein Kinase C; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride; Synaptosomes; Tetrodotoxin | 1994 |
Dopamine DA2-receptor activation inhibits noradrenaline release in human kidney slices.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Brimonidine Tartrate; Calcium; Dopamine Agents; Ergolines; Fenoldopam; Humans; In Vitro Techniques; Indoles; Kidney Cortex; Middle Aged; Norepinephrine; Oxidopamine; Pyridines; Quinoxalines; Quinpirole; Receptors, Dopamine D2; Sulpiride; Tetrodotoxin | 1993 |
Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 6-Cyano-7-nitroquinoxaline-2,3-dione; Action Potentials; Animals; Corpus Striatum; Denervation; Dopamine; Dopamine Agents; Ergolines; Male; Oxidopamine; Parkinson Disease, Secondary; Quinoxalines; Quinpirole; Rats; Rats, Wistar; Substantia Nigra; Synaptic Membranes; Tetrodotoxin | 1993 |
Inhibitory action of dopamine involves a subthreshold Cs(+)-sensitive conductance in neostriatal neurons.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Action Potentials; Animals; Benzazepines; Cesium; Cyclic AMP; Dopamine; Dopamine Agonists; Electric Stimulation; Electrophysiology; Evoked Potentials; Haloperidol; In Vitro Techniques; Ion Channels; Membrane Potentials; Neostriatum; Neurons; Patch-Clamp Techniques; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride; Tetrodotoxin | 1996 |
Differential inhibition of secretagogue-stimulated sodium uptake in adrenal chromaffin cells by activation of D4 and D5 dopamine receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adrenal Medulla; Analysis of Variance; Animals; Benzazepines; Biological Transport; Bromocriptine; Cattle; Cells, Cultured; Chromaffin Cells; Colforsin; Dimethylphenylpiperazinium Iodide; Kinetics; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D4; Receptors, Dopamine D5; Sodium; Tetrodotoxin; Veratridine | 1996 |
Modulation of GABA release by dopamine in the substantia nigra.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Basal Metabolism; Benzazepines; Dopamine; Dopamine Agonists; Dopamine Antagonists; gamma-Aminobutyric Acid; Male; Membrane Potentials; Potassium; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Substantia Nigra; Tetrodotoxin | 1999 |
Neurochemical evidence of dopamine release by lateral olivocochlear efferents and its presynaptic modulation in guinea-pig cochlea.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Axons; Bromocriptine; Cadmium Chloride; Calcium Signaling; Cochlea; Cochlear Nucleus; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dopamine Uptake Inhibitors; Drug Interactions; Efferent Pathways; Feedback; Guinea Pigs; Male; Models, Neurological; Neuroprotective Agents; Nomifensine; Olivary Nucleus; Piribedil; Quinpirole; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Presynaptic; Sulpiride; Tetrodotoxin | 1999 |
Dopamine activation of endogenous cannabinoid signaling in dorsal striatum.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amides; Animals; Arachidonic Acids; Calcium; Cannabinoid Receptor Modulators; Corpus Striatum; Dopamine; Dopamine Agonists; Dopamine Antagonists; Endocannabinoids; Ethanolamines; Gas Chromatography-Mass Spectrometry; Glycerides; Hyperkinesis; Male; Microdialysis; Motor Activity; Oleic Acids; Palmitic Acids; Piperidines; Polyunsaturated Alkamides; Potassium; Pyrazoles; Quinpirole; Raclopride; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Dopamine D2; Receptors, Drug; Rimonabant; Salicylamides; Signal Transduction; Single-Blind Method; Sodium; Tetrodotoxin | 1999 |
The D1 dopamine receptor agonist SKF-38393 stimulates the release of glutamate in the hippocampus.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Colforsin; Dopamine Agonists; Glutamic Acid; Hippocampus; Rats; Receptors, Dopamine D1; Tetrodotoxin | 1999 |
Dopamine D1/D5 receptor activation modulates a persistent sodium current in rat prefrontal cortical neurons in vitro.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Alkaloids; Animals; Benzazepines; Benzophenanthridines; Cyclic AMP-Dependent Protein Kinases; Dopamine; Dopamine Agonists; Enzyme Inhibitors; In Vitro Techniques; Kinetics; Male; Membrane Potentials; Patch-Clamp Techniques; Phenanthridines; Prefrontal Cortex; Protein Kinase C; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D5; Sodium; Tetrodotoxin | 2000 |
Dopamine modulates sodium currents in cochlear spiral ganglion neurons.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Action Potentials; Animals; Benzazepines; Bromocriptine; Dopamine; Dopamine Agonists; Dopamine Antagonists; In Vitro Techniques; Mice; Mice, Inbred C57BL; Neurons, Afferent; Patch-Clamp Techniques; Quinpirole; Receptors, Dopamine D1; Receptors, Dopamine D2; Sodium; Spiral Ganglion; Tetrodotoxin | 2001 |
Activation of dopamine D1-like receptors excites LTS interneurons of the striatum.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Action Potentials; Animals; Animals, Newborn; Benzazepines; Cell Size; Dopamine; Dopamine Antagonists; Electric Stimulation; Excitatory Amino Acid Antagonists; Interneurons; Neostriatum; Organ Culture Techniques; Rats; Receptors, Dopamine D1; Sodium Channel Blockers; Sulpiride; Synaptic Transmission; Tetrodotoxin | 2002 |
Excitatory actions of dopamine via D1-like receptors in the rat lateral geniculate nucleus.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Action Potentials; Adrenergic alpha-Antagonists; Analysis of Variance; Anesthetics, Local; Animals; Animals, Newborn; Benzazepines; Bromocriptine; Carbazoles; Colforsin; Cyclic AMP; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Enzyme Inhibitors; Geniculate Bodies; In Vitro Techniques; Indoles; Neurons; Patch-Clamp Techniques; Prazosin; Pyrimidines; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Tetrodotoxin; Thionucleotides | 2005 |
In vivo patch-clamp analysis of dopaminergic antinociceptive actions on substantia gelatinosa neurons in the spinal cord.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 6-Cyano-7-nitroquinoxaline-2,3-dione; Action Potentials; Afferent Pathways; Animals; Barium Compounds; Chlorides; Dopamine; Dopamine Agents; Drug Interactions; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Guanosine Diphosphate; Male; Nociceptors; Pain; Patch-Clamp Techniques; Physical Stimulation; Quinpirole; Rats; Rats, Sprague-Dawley; Skin; Sodium Channel Blockers; Spinal Cord; Substantia Gelatinosa; Tetrodotoxin; Thionucleotides | 2011 |
Dopaminergic modulation of ganglion-cell photoreceptors in rat.
Topics: 1-Methyl-3-isobutylxanthine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Actins; Animals; Carbazoles; Cells, Cultured; Colforsin; Cyclic AMP; Dopamine; Dopamine Agonists; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Gene Expression Regulation; In Vitro Techniques; Light; Light Signal Transduction; Male; Membrane Potentials; Patch-Clamp Techniques; Photic Stimulation; Photoreceptor Cells; Pyrroles; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Retina; Retinal Ganglion Cells; Rod Opsins; Sodium Channel Blockers; Tetrodotoxin; Visual Pathways | 2012 |
Stimulation of dopamine D2-like receptors in the lumbosacral defaecation centre causes propulsive colorectal contractions in rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Anesthetics, Local; Animals; Benzazepines; Colon; Defecation; Dopamine; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Dopaminergic Neurons; Gastrointestinal Motility; Haloperidol; Injections, Spinal; Lumbosacral Region; Male; Muscle Contraction; Quinpirole; Rats, Sprague-Dawley; Receptors, Dopamine D2; Rectum; Spinal Cord; Tetrodotoxin | 2016 |
Postnatal development of the dopaminergic signaling involved in the modulation of intestinal motility in mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Animals, Newborn; Cyclic AMP; Dideoxyadenosine; Dopamine; Enteric Nervous System; Estrenes; Gastrointestinal Diseases; Gastrointestinal Motility; Intestine, Small; Mice; Mice, Inbred C57BL; Pyrrolidinones; Signal Transduction; Tetrodotoxin; Type C Phospholipases | 2016 |